![Robert Lechleider](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Lechleider
Chief Tech/Sci/R&D Officer at
IMMUNOME, INC.
Net worth: 334 908 $ as of 30/06/2026
Profile
Robert Lechleider is currently Chief Medical Officer at Immunome, Inc. since 2023.
Formerly, Dr. Lechleider was Chief Medical Officer at OncoResponse, Inc. from 2020 to 2023 and Senior Vice President-Clinical Development at Seagen, Inc. from 2016 to 2020.
Education includes undergraduate studies at Princeton University and a doctorate from the University of Illinois College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOME, INC. 0.01% | 02/07/2026 | 15,805 ( 0.01% ) | 334 908 $ | 30/06/2026 |
Robert Lechleider active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOME, INC. | Chief Tech/Sci/R&D Officer | 19/10/2023 |
Former positions of Robert Lechleider
| Companies | Position | End |
|---|---|---|
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Chief Tech/Sci/R&D Officer | 01/10/2023 |
| SEAGEN INC. | Chief Tech/Sci/R&D Officer | 01/04/2020 |
Training of Robert Lechleider
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois College of Medicine
 University of Illinois College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Health Technology |
- Stock Market
- Insiders
- Robert Lechleider
